0001567619-22-016896.txt : 20220901 0001567619-22-016896.hdr.sgml : 20220901 20220901124600 ACCESSION NUMBER: 0001567619-22-016896 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220830 FILED AS OF DATE: 20220901 DATE AS OF CHANGE: 20220901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cowen Aaron CENTRAL INDEX KEY: 0001869640 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40560 FILM NUMBER: 221220336 MAIL ADDRESS: STREET 1: 540 MADISON AVENUE, 7TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROKIDNEY CORP. CENTRAL INDEX KEY: 0001850270 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 981586514 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 FRONTIS PLAZA BLVD. STREET 2: SUITE 250 CITY: WINSTON-SALEM STATE: NC ZIP: 27103 BUSINESS PHONE: 336-999-7028 MAIL ADDRESS: STREET 1: 2000 FRONTIS PLAZA BLVD. STREET 2: SUITE 250 CITY: WINSTON-SALEM STATE: NC ZIP: 27103 FORMER COMPANY: FORMER CONFORMED NAME: Social Capital Suvretta Holdings Corp. III DATE OF NAME CHANGE: 20210310 4 1 doc1.xml FORM 4 X0306 4 2022-08-30 0 0001850270 PROKIDNEY CORP. PROK 0001869640 Cowen Aaron C/O SUVRETTA CAPITAL MANAGEMENT, LLC 540 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 0 0 1 0 Class A Ordinary Shares 2022-08-30 4 P 0 706 7.49 A 6270006 I See footnote Class A Ordinary Shares 2022-08-31 4 P 0 1062 8.93 A 6271068 I See footnote Class A Ordinary Shares 2022-08-31 4 P 0 2100 8.94 A 6273168 I See footnote See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 See Exhibit 99.1 Exhibit List: ------------ Exhibit 99.1 Explanation of Responses /s/ Aaron Cowen 2022-09-01 EX-99.1 2 c090122a.htm EXPLANATION OF RESPONSES
Exhibit 99.1

Explanation of Responses:

(1)
Reflects Class A ordinary shares, par value $0.0001 per share, of ProKidney Corp. (the “Class A ordinary shares”) directly held by Averill Master Fund, Ltd. (the “Averill Fund”).
(2)
Reflects 3,183,006 Class A ordinary shares directly held by the Averill Fund and 3,087,000 Class A ordinary shares directly held by SVAV Sponsor III, LLC (“SVAV”).
(3)
Reflects 3,184,068 Class A ordinary shares directly held by the Averill Fund and 3,087,000 Class A ordinary shares directly held by SVAV.
(4)
Reflects 3,186,168 Class A ordinary shares directly held by the Averill Fund and 3,087,000 Class A ordinary shares directly held by SVAV.
(5)
Mr. Cowen (i) may be deemed to control SVAV and therefore may be deemed to beneficially own the  Class A ordinary shares held by SVAV and (ii) may be deemed to control Suvretta Capital Management, LLC, the investment manager of the Averill Fund, and therefore may be deemed to beneficially own the Class A ordinary shares held by the Averill Fund.  Mr. Cowen disclaims beneficial ownership of the Class A ordinary shares reported herein except to the extent of any indirect pecuniary interest therein.